Drug
Hyaluronidase
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Autoimmune Disorder | 254 | 482.9 | 614.5 | signal |
| 2 | Helicobacter Infection | 262 | 467.2 | 599.7 | signal |
| 3 | Folliculitis | 241 | 423.1 | 531.0 | signal |
| 4 | Bursitis | 237 | 354.9 | 443.4 | signal |
| 5 | Hand Deformity | 243 | 335.2 | 421.5 | signal |
| 6 | Pemphigus | 218 | 316.1 | 387.2 | signal |
| 7 | Joint Range Of Motion Decreased | 204 | 274.5 | 331.4 | signal |
| 8 | Wound Infection | 160 | 264.6 | 305.8 | signal |
| 9 | Sciatica | 216 | 244.5 | 298.9 | signal |
| 10 | Hypercholesterolaemia | 127 | 238.2 | 266.7 | signal |
| 11 | Pericarditis | 214 | 230.4 | 281.0 | signal |
| 12 | Obesity | 192 | 215.7 | 257.3 | signal |
| 13 | Synovitis | 211 | 209.5 | 254.7 | signal |
| 14 | Lower Limb Fracture | 221 | 207.4 | 254.7 | signal |
| 15 | Laryngitis | 124 | 204.6 | 228.4 | signal |
| 16 | Foot Deformity | 123 | 198.5 | 221.4 | signal |
| 17 | Glossodynia | 233 | 186.5 | 232.0 | signal |
| 18 | Fibromyalgia | 236 | 173.8 | 216.8 | signal |
| 19 | Irritable Bowel Syndrome | 203 | 169.9 | 204.8 | signal |
| 20 | Liver Injury | 200 | 147.7 | 177.5 | signal |
| 21 | Pulmonary Fibrosis | 150 | 140.1 | 160.3 | signal |
| 22 | Wound | 217 | 139.3 | 170.3 | signal |
| 23 | Red Blood Cell Sedimentation Rate Increased | 85 | 136.8 | 147.3 | signal |
| 24 | Hepatic Cirrhosis | 141 | 134.6 | 152.7 | signal |
| 25 | Sleep Disorder Due To A General Medical Condition | 121 | 133.5 | 148.6 | signal |
| 26 | Hip Arthroplasty | 112 | 131.6 | 145.2 | signal |
| 27 | Type 2 Diabetes Mellitus | 249 | 131.5 | 166.3 | signal |
| 28 | Joint Dislocation | 75 | 127.0 | 135.6 | signal |
| 29 | Impaired Healing | 227 | 123.3 | 152.3 | signal |
| 30 | Systemic Lupus Erythematosus | 238 | 120.0 | 149.9 | signal |
| 31 | Prescribed Overdose | 119 | 109.6 | 121.7 | signal |
| 32 | Night Sweats | 191 | 105.7 | 125.8 | signal |
| 33 | Blood Cholesterol Increased | 265 | 101.2 | 130.1 | signal |
| 34 | Weight Fluctuation | 59 | 100.8 | 106.1 | signal |
| 35 | Pregnancy | 114 | 100.4 | 111.0 | signal |
| 36 | Road Traffic Accident | 233 | 99.1 | 123.2 | signal |
| 37 | Knee Arthroplasty | 116 | 99.1 | 109.7 | signal |
| 38 | Lower Respiratory Tract Infection | 243 | 95.5 | 119.9 | signal |
| 39 | Psoriatic Arthropathy | 211 | 93.4 | 113.4 | signal |
| 40 | Osteoarthritis | 221 | 92.6 | 113.7 | signal |
| 41 | Liver Disorder | 218 | 87.6 | 107.1 | signal |
| 42 | Ear Infection | 129 | 86.5 | 96.9 | signal |
| 43 | Frequent Bowel Movements | 129 | 85.3 | 95.6 | signal |
| 44 | Delirium | 161 | 82.8 | 95.7 | signal |
| 45 | Arthropathy | 250 | 79.7 | 100.8 | signal |
| 46 | Blister | 247 | 78.4 | 98.8 | signal |
| 47 | Discomfort | 264 | 77.5 | 99.4 | signal |
| 48 | Lung Disorder | 212 | 77.0 | 93.6 | signal |
| 49 | Stomatitis | 251 | 73.6 | 93.1 | signal |
| 50 | Respiratory Disorder | 123 | 72.9 | 81.2 | signal |
| 51 | Hepatic Enzyme Increased | 272 | 71.2 | 92.1 | signal |
| 52 | Musculoskeletal Pain | 211 | 71.0 | 86.2 | signal |
| 53 | Rectal Haemorrhage | 166 | 68.4 | 79.4 | signal |
| 54 | Inflammation | 191 | 66.1 | 78.7 | signal |
| 55 | Gait Inability | 123 | 66.1 | 73.6 | signal |
| 56 | White Blood Cell Count Increased | 139 | 64.2 | 72.6 | signal |
| 57 | Infusion Related Reaction | 232 | 62.4 | 77.4 | signal |
| 58 | Colitis Ulcerative | 156 | 62.2 | 71.4 | signal |
| 59 | Oedema | 186 | 61.1 | 72.3 | signal |
| 60 | Ill-defined Disorder | 205 | 59.9 | 72.3 | signal |
| 61 | Laboratory Test Abnormal | 99 | 59.7 | 65.0 | signal |
| 62 | Contraindicated Product Administered | 100 | 58.9 | 64.2 | signal |
| 63 | Wheezing | 193 | 58.0 | 69.1 | signal |
| 64 | Mobility Decreased | 230 | 57.1 | 70.6 | signal |
| 65 | Joint Stiffness | 84 | 56.9 | 61.1 | signal |
| 66 | Incorrect Route Of Product Administration | 53 | 56.0 | 58.6 | signal |
| 67 | C-reactive Protein Increased | 109 | 53.2 | 58.5 | signal |
| 68 | Osteoporosis | 118 | 50.9 | 56.4 | signal |
| 69 | Injury | 200 | 50.3 | 60.3 | signal |
| 70 | Dry Mouth | 225 | 49.3 | 60.7 | signal |
| 71 | Contusion | 260 | 48.0 | 61.3 | signal |
| 72 | Swelling | 249 | 47.3 | 59.7 | signal |
| 73 | Maternal Exposure During Pregnancy | 232 | 46.7 | 57.8 | signal |
| 74 | Prescribed Underdose | 52 | 46.3 | 48.4 | signal |
| 75 | Gastrointestinal Disorder | 229 | 46.0 | 56.8 | signal |
| 76 | Musculoskeletal Stiffness | 221 | 44.8 | 54.8 | signal |
| 77 | Pancreatitis | 133 | 44.6 | 50.1 | signal |
| 78 | Sinusitis | 252 | 43.5 | 55.0 | signal |
| 79 | Amnesia | 154 | 41.8 | 48.0 | signal |
| 80 | Asthma | 262 | 41.5 | 53.0 | signal |
| 81 | Feeling Hot | 129 | 37.3 | 41.7 | signal |
| 82 | General Physical Health Deterioration | 232 | 35.8 | 44.3 | signal |
| 83 | Rheumatoid Arthritis | 227 | 35.6 | 43.8 | signal |
| 84 | Therapy Non-responder | 87 | 34.6 | 37.3 | signal |
| 85 | Ear Pain | 37 | 33.8 | 34.8 | signal |
| 86 | Therapeutic Product Effect Decreased | 84 | 33.6 | 36.1 | signal |
| 87 | Arthritis | 145 | 32.7 | 37.1 | signal |
| 88 | Joint Swelling | 220 | 32.4 | 39.6 | signal |
| 89 | Abdominal Discomfort | 297 | 31.5 | 41.7 | signal |
| 90 | Hypoaesthesia | 250 | 29.6 | 37.2 | signal |
| 91 | Sleep Disorder | 112 | 28.4 | 31.3 | signal |
| 92 | Confusional State | 255 | 27.9 | 35.3 | signal |
| 93 | Infection | 221 | 27.2 | 33.2 | signal |
| 94 | Muscular Weakness | 169 | 26.4 | 30.6 | signal |
| 95 | Hypersensitivity | 275 | 26.3 | 34.0 | signal |
| 96 | Back Injury | 16 | 26.2 | 26.6 | signal |
| 97 | Alopecia | 286 | 25.8 | 33.7 | signal |
| 98 | Drug Intolerance | 138 | 25.4 | 28.7 | signal |
| 99 | Migraine | 135 | 25.2 | 28.4 | signal |
| 100 | Neutrophil Count Increased | 14 | 24.2 | 24.4 | signal |
| 101 | Peripheral Swelling | 205 | 23.7 | 28.4 | signal |
| 102 | Intraocular Pressure Increased | 17 | 23.5 | 23.8 | signal |
| 103 | Dyspepsia | 129 | 23.3 | 26.0 | signal |
| 104 | Urticaria | 218 | 23.2 | 28.2 | signal |
| 105 | Treatment Failure | 106 | 22.9 | 25.1 | signal |
| 106 | Loss Of Personal Independence In Daily Activities | 61 | 22.7 | 23.9 | signal |
| 107 | Hypertension | 271 | 22.7 | 29.1 | signal |
| 108 | Chest Pain | 236 | 22.5 | 27.9 | signal |
| 109 | Drug Hypersensitivity | 241 | 22.0 | 27.4 | signal |
| 110 | Nasopharyngitis | 227 | 21.8 | 26.7 | signal |
| 111 | Paraesthesia | 193 | 21.7 | 25.7 | signal |
| 112 | Abdominal Pain Upper | 240 | 20.7 | 25.7 | signal |
| 113 | Muscle Spasms | 211 | 20.4 | 24.6 | signal |
| 114 | Memory Impairment | 156 | 20.1 | 23.0 | signal |
| 115 | Oedema Peripheral | 138 | 20.0 | 22.5 | signal |
| 116 | Intentional Product Use Issue | 99 | 20.0 | 21.7 | signal |
| 117 | Decreased Appetite | 258 | 19.7 | 25.0 | signal |
| 118 | Immunodeficiency | 16 | 19.3 | 19.5 | signal |
| 119 | Weight Increased | 234 | 18.6 | 23.0 | signal |
| 120 | Eyelid Oedema | 12 | 18.2 | 18.3 | signal |
| 121 | Adrenal Insufficiency | 12 | 17.8 | 17.9 | signal |
| 122 | Lymphopenia | 14 | 17.6 | 17.8 | signal |
| 123 | Sensory Disturbance | 16 | 17.6 | 17.8 | signal |
| 124 | Visual Impairment | 122 | 17.6 | 19.5 | signal |
| 125 | Medication Error | 54 | 17.2 | 18.0 | signal |
| 126 | Ejection Fraction Decreased | 15 | 17.1 | 17.3 | signal |
| 127 | Exposure During Pregnancy | 58 | 16.5 | 17.3 | signal |
| 128 | Coeliac Disease | 9 | 16.2 | 16.4 | signal |
| 129 | Taste Disorder | 18 | 15.9 | 16.2 | signal |
| 130 | Liver Function Test Increased | 19 | 15.8 | 16.0 | signal |
| 131 | Adverse Event | 82 | 15.8 | 16.9 | signal |
| 132 | Eyelid Ptosis | 9 | 15.7 | 15.8 | signal |
| 133 | Product Administered At Inappropriate Site | 16 | 15.6 | 15.8 | signal |
| 134 | Anxiety | 249 | 15.5 | 19.3 | signal |
| 135 | Retinal Detachment | 8 | 15.4 | 15.5 | signal |
| 136 | Blood Urea Increased | 14 | 14.7 | 14.9 | signal |
| 137 | Condition Aggravated | 248 | 14.6 | 18.1 | signal |
| 138 | Disability | 16 | 14.3 | 14.5 | signal |
| 139 | Post Procedural Complication | 15 | 13.8 | 14.0 | signal |
| 140 | Deformity | 7 | 13.2 | 13.3 | signal |
| 141 | Visual Acuity Reduced | 25 | 13.2 | 13.5 | signal |
| 142 | Insomnia | 198 | 13.2 | 15.6 | signal |
| 143 | Asthenia | 274 | 12.9 | 16.5 | signal |
| 144 | Depression | 166 | 12.9 | 14.8 | signal |
| 145 | Pyrexia | 245 | 12.5 | 15.6 | signal |
| 146 | Mydriasis | 9 | 12.4 | 12.5 | signal |
| 147 | Adverse Drug Reaction | 62 | 12.3 | 12.9 | signal |
| 148 | Muscle Twitching | 16 | 12.3 | 12.4 | signal |
| 149 | Gait Disturbance | 130 | 12.0 | 13.4 | signal |
| 150 | Product Use Issue | 125 | 11.8 | 13.1 | signal |
| 151 | Arthralgia | 276 | 11.8 | 15.1 | signal |
| 152 | Blood Bilirubin Increased | 18 | 11.8 | 11.9 | signal |
| 153 | Epilepsy | 20 | 11.6 | 11.8 | signal |
| 154 | Drug-induced Liver Injury | 20 | 11.5 | 11.7 | signal |
| 155 | Ascites | 19 | 11.4 | 11.6 | signal |
| 156 | Blood Alkaline Phosphatase Increased | 16 | 11.4 | 11.5 | signal |
| 157 | Weight Decreased | 174 | 11.1 | 12.8 | signal |
| 158 | Pruritus | 233 | 10.9 | 13.4 | signal |
| 159 | Generalised Tonic-clonic Seizure | 10 | 10.8 | 10.9 | signal |
| 160 | Osteopenia | 9 | 10.5 | 10.5 | signal |
| 161 | Neck Pain | 33 | 10.4 | 10.7 | signal |
| 162 | Drug Administered At Inappropriate Site | 6 | 9.9 | 10.0 | signal |
| 163 | Malaise | 241 | 9.7 | 11.9 | signal |
| 164 | Vomiting | 252 | 9.5 | 11.8 | signal |
| 165 | Underdose | 39 | 9.5 | 9.7 | signal |
| 166 | Device Related Infection | 8 | 9.2 | 9.2 | signal |
| 167 | Dizziness | 256 | 9.1 | 11.3 | signal |
| 168 | Rash | 222 | 9.1 | 10.9 | signal |
| 169 | Cerebral Haemorrhage | 18 | 8.9 | 9.0 | signal |
| 170 | Back Disorder | 8 | 8.7 | 8.7 | signal |
| 171 | Muscle Spasticity | 6 | 8.6 | 8.6 | signal |
| 172 | Crying | 17 | 8.3 | 8.4 | signal |
| 173 | Agitation | 28 | 6.7 | 6.9 | signal |
| 174 | Depressed Mood | 20 | 6.7 | 6.8 | signal |
| 175 | Rebound Effect | 4 | 6.2 | 6.3 | signal |
| 176 | Eye Swelling | 13 | 6.2 | 6.3 | signal |
| 177 | Eye Inflammation | 3 | 5.6 | 5.6 | signal |
| 178 | Inflammatory Bowel Disease | 3 | 5.4 | 5.4 | signal |
| 179 | Osteonecrosis Of Jaw | 7 | 5.0 | 5.0 | signal |
| 180 | Respiratory Depression | 3 | 4.3 | 4.3 | signal |
| 181 | Neoplasm Progression | 8 | 4.0 | 4.1 | signal |
| 182 | Psoriasis | 22 | 3.0 | 3.0 | signal |
| 183 | Foetal Exposure During Pregnancy | 13 | 2.8 | 2.9 | signal |
| 184 | Pharmaceutical Product Complaint | 3 | 2.0 | 2.0 | no signal |
| 185 | Device Breakage | 3 | 1.4 | 1.4 | no signal |